I’m confused, it seems the info in this pr is for the critical patients only, what about the severe patients? I am sure, given this data and the safety that vyrologix will get an EUA however. The other thing we should be aware of is that these patients got 2 doses, a patient may need more than that and the mortality in both severe and critical likely would be even more compelling! This is great news, final proof that there is a treatment that works significantly!